Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis

American Journal of Pathology

Volumn 155, Issue 4, 1999, Pages 1327-1339

  Kravtsov, Vladimir D ^a   Daniel, Thomas O ^a   Koury, Mark J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA FRAGMENT; ETOPOSIDE;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0032857484     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65235-2     Document Type: Article

References (53)

1. Sachs L, Lotem J: Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 1993, 82:15-21
2. Kerr JFR, Winterford CM, Harmon BV: Apoptosis: its significance in cancer and cancer therapy. Cancer 1994, 73:2013-2026
3. Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 1997, 89:1845-1853
4. Sekiguchi I, Suzuki M, Ohwada M, Sato I: Apoptosis as a criterion for sensitivity of uterine cervical adenocarcinoma to cisplatin. Oncol Rep 1998, 5:1077-1078
5. Fan W, Johnson KR, Miller III MC: In vitro evaluation of combination chemotherapy against human tumor cells. Oncol Rep 1998 5:1035-1042
6. Kamesaki H: Mechanisms involved in chemotherapy-induced apoptosis and their implications in cancer chemotherapy. Int J Hematol 1998, 68:29-43
7. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257
8. Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 1981, 68:251-306
9. Cohen JJ: Overview: mechanisms of apoptosis. Immunol Today 1993, 14:126-130
10. Hockenbery D: Defining apoptosis. Am J Pathol 1995, 146:16-19
11. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284: 555-556
12. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998, 281:1309-1312
13. Mower DA, Peckham DW, Illera VA, Fishbaugh JK, Stunz LL, Ashman RF: Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J Immunol 1994, 152:4832-4842
14. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, van Schie RCAA, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995, 182:1545-1556
15. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998, 281:1312-1316
16. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 1992, 13:795-808
17. Gorczyca W, Gong J, Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993, 53:1945-1951
18. Ormerod MG, Collins MK, Rodriguez-Tarduchy G, Robertson D: Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods. J Immunol Methods 1992, 153: 57-65
19. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehen RMJ, Pals ST, van Oers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994, 84:1415-1420
20. Durrieu F, Belloc F, Lacoste L, Dumain P, Chabrol J, Dachary-Prigent J, Morjani H, Boisseau M, Reiffers J, Bernard P, Lacombe F: Caspase activation is an early event in anthracycline-induced apoptosis and allows detection of apoptotic cells before they are ingested by phagocytes. Exp Cell Res 1998, 240:165-175
21. Kravtsov VD: A novel microculture kinetic assay (MiCK assay) for malignant cell growth and chemosensitivity. Eur J Cancer 1994, 30A:1564-1570
22. Kravtsov V, Fabian I: Automated monitoring of apoptosis in suspension cell cultures. Lab Invest 1996, 74:557-570
23. Kravtsov V, Greer J, Whitlock J, Koury M: Use of the microculture kinetic (MiCK) assay of apoptosis to determine chemosensitivities of leukemias. Blood 1998, 92:968-980
24. Barry MA, Reynolds JE, Eastman A: Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res 1993, 53:2349-2357
25. Martins LM, Mesner PW, Kottke TJ, Basi GS, Sinha S, Tung JS, Svingen PA, Madden BJ, Takahashi A, McCormick DJ, Earnshaw WC, Kaufmann SH: Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis Blood 1997, 90:4283-4296
26. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z: The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 1993, 53:3186-3192
27. Shi Y, Frankel A, Radvanyi LG, Penn LZ, Miller RG, Mills GB: Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res 1995, 55:1982-1988
28. Long BH: Mechanisms of action of teniposide (VM-26) and comparison with etoposide (VP-16). Semin Oncol 1992, 19:3-19
29. Damayanthi Y, Lown JW: Podophyllotoxins: current status and recent developments. Curr Med Chem 1998, 5:205-252
30. Parker RJ, Eastman A, Bostick-Bruton F, Reed E: Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J Clin Invest 1991, 87:772-777
31. Calvert H, Judson I, van der Vijgh WJ: Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity. Cancer Surv 1993, 17:189-217
32. Pulkkinen JO, Elomaa L, Joensuu H, Martikainen P, Servomaa K, Grenman R: Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck cancer. J Cancer Res Clin Oncol 1996, 122:214-218
33. Collins JA, Schandi CA, Young KK, Vesely J, Willingham MC: Major DNA fragmentation is a late event in apoptosis. J Histochem Cytochem 1997, 45:923-934
34. Messam CA, Pittman RN: Asynchrony and commitment to die during apoptosis. Exp Cell Res 1998, 238:389-398
35. Ferlini C, Di Cesare S, Rainaldi G, Malorni W, Samoggia P, Biselli R, Fattorossi A: Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry 1996, 24:106-115
36. Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon ML: Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 1995, 130: 157-167
37. Shapiro HM: Practical Flow Cytometry. New York, Wiley-Liss, 1993, pp 115-121
38. Katsen AD, Vollmar B, Mestres-Ventura P, Menger MD: Cell surface and nuclear changes during TNF-α-induced apoptosis in WEHI 164 murine fibrosarcoma cells. A correlative light, scanning, and transmission electron microscopical study. Virchows Arch 1998, 433:75-83
39. Phelps PC, Smith MW, Trump BF: Cytosolic ionized calcium and bleb formation after acute cell injury of cultured rabbit renal tubule cells. Lab Invest 1989, 60:630-642
40. 2+ deregulation and blebbing after HgCl2 injury to cultured rabbit proximal tubule cells as determined by digital imaging microscopy. Proc Natl Acad Sci USA 1991, 88:4926-4930
41. Nicotera R, Thor H, Orrenius S: Cytosolic-free Ca2+, and cell killing in hepatoma 1c1c7 cells exposed to chemical anoxia. FASEB J 1989, 3:59-64
42. Gores GJ, Herman B, Lemasters JJ: Plasma membrane bleb formation and rupture: a common feature of hepatocellular injury. Hepatology 1990, 11:690-698
43. Herman B, Gores GJ, Nieminen A-L, Kawanishi T, Harman A, Lemasters JJ: Calcium and pH in anoxic and toxic injury. Toxicology 1990, 21:127-143
44. Trump BF, Berezesky IK, Chang SH, Phelps PC: The pathways of cell death: oncosis, apoptosis, and necrosis Toxicol Pathol 1997, 25: 82-88
45. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehen RMJ, Pals ST, van Oers MHJ: Annexin V for flow cylometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994, 84:1415-1420
46. Cohen GM, Sun X-M, Snowden RT, Dinsdale D, Skilleter DN: Key morphological features of apoptosis may occur in the absence in internucleosomal DNA fragmentation. Biochem J 1992, 286:331-334
47. Collins RJ, Harmon BV, Gobe GC, Kerr JFR: Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 1992, 61:451-453
48. Schulze-Osthoff K, Walczak H, Droge W, Krammer PH: Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 1994, 127:15-20
49. Kelley LL, Koury MJ, Bondurant MC, Koury ST, Sawyer ST, Wickrema A: Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 1993, 82:2340-2352
50. Lazebnik Y, Kaufmann S, Desnoyers S, Poirier G, Earnshaw W: Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371:346-347
51. Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufman SH, Earnshaw WC: Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptolic execution. Proc Natl Acad Sci USA 1995, 92:9042-9046
52. McCarthy NJ, Evan GI: Methods for detecting and quantifying apoptosis. Curr Top Dev Biol 1998, 36:259-278
53. McCarthy NJ, Whyte MKB, Gilbert CS, Evan GI: Inhibition of Ced-3/ ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol 1997, 136215-227